FerriScan Recognised for Contribution to Global Health Issue

Resonance Health has achieved another milestone in its provision of MRI-based measurement services to the global clinical community, having now provided the Company’s lead product, FerriScan® to more than 30,000 patients worldwide.

Read more

Resonance Health News December 2015

Resonance Health is happy to provide you with our latest quarterly newsletter where you can find an update on our busy end to 2015.

To read the newsletter please click here

We would like to take this opportunity to wish everyone a happy holidays and a safe and healthy 2016!

FerriScan Case Study Challenge

FerriScan R2-MRI is now the recognised global gold standard in measurement of liver iron concentration. It has largely replaced liver biopsy in many countries, saving patients the discomfort and risks associated with invasive procedures. The scientific rigor underpinning FerriScan’s calibration and validation, together with the quality-assured service delivery, means that clinicians now confidently use the reported results to monitor their patients’ liver iron concentration (LIC) and to optimise their treatment.

Read more

30,000 FerriScans and ASH

Resonance Health is exhibiting at the American Society of Hematology (ASH) Conference in Orlando Florida from 5 – 8  December.

Read more

Resonance Health News September 2015

Resonance Health is happy to provide you with an update on our recent activity via our latest quarterly newsletter.

To read the newsletter please click here

Resonance Health Appoints New Distributor, KNS in Canada

Resonance Health is pleased to announce the appointment of KNS in Canada who will launch a local presence for FerriScan at the forthcoming 2015 Pan-Canadian Thalassemia Conference taking place in Toronto on September 25-26th

Read more